Meanwhile, the drug development unit, provisionally dubbed SpinCo, will retain ties with Gilead, which will remain a collaboration partner and have representation on its board. The decision comes ...

The board of directors of Orogen unanimously recommends that Shareholders vote "FOR" the Arrangement Resolution. Please visit the Orogen's Meeting webpage for complete details and links to all ...

VANCOUVER, BC / ACCESS Newswire / June 18, 2025 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that Institutional Shareholder Services Inc ...